Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Nelivaptan

Generic Name: Nelivaptan

Drug Type: Small Molecule

Chemical Formula: C_₃₀H_₃₂ClN_₃O_₈S

CAS Number: 439687-69-1

Unique Ingredient Identifier: 3TY57MQ4OA

Overview

Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.

Background

Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder

Phase 2

Completed

Posted: 2006/09/08

Sponsor:Sanofi

ID:NCT00374166

An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder

Phase 2

Completed

Posted: 2006/08/08

Sponsor:Sanofi

ID:NCT00361491

An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder

Phase 2

Completed

Posted: 2006/08/01

Sponsor:Sanofi

ID:NCT00358631

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy

Drug Development Updates

Nelivaptan

Overview

Background

Indication

Associated Conditions

Clinical Trials

FDA Approved Products

Singapore Approved Products

Related News

HMNC Brain Health Completes Patient Randomization in Phase 2b Trial of BH-200 for Major Depressive Disorder

Drug Development Updates